Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001225208-10-005416)

Filing Details

Accession Number:: 0001225208-10-005416
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2010-02-24 12:00:00
Reporting Period:: 2010-02-22

Filing Date:: 2010-02-24
Accepted Time:: 2010-02-24 11:07:23
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
732485	Genzyme Corp	GENZ	Biological Products, (No Disgnostic Substances) (2836)	061047163

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1021038	A Henri Termeer	500 Kendall Street Cambridge MA 02142	Chmn, President And Ceo	Yes	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Genzyme Common Stock (Genz)	Acquisiton	2010-02-22	100,000	$26.50	724,630	No	4	M	Direct
Genzyme Common Stock (Genz)	Disposition	2010-02-22	100,000	$55.78	624,630	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Genzyme Common Stock (Genz)	Stock Option (right to buy)	Disposition	2010-02-22	100,000	$26.50	100,000	$26.50

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
100,000	2002-02-28	2010-05-25	No	4	M	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Genzyme Common Stock (Genz)	18,360	Indirect	By 401(k)
Genzyme Common Stock (Genz)	2,371	Indirect	By Spouse
Genzyme Common Stock (Genz)	1,256	Indirect	By Trust

Footnotes

The sales reported were effected pursuant to a Rule 10b5-1 plan adopted by the reporting person on February 23, 2009.